sb 203580 has been researched along with equol in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (equol) | Trials (equol) | Recent Studies (post-2010) (equol) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 672 | 90 | 348 |
Protein | Taxonomy | sb 203580 (IC50) | equol (IC50) |
---|---|---|---|
Estrogen receptor | Homo sapiens (human) | 5.876 | |
Estrogen receptor beta | Homo sapiens (human) | 5.571 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chae, B; Chung, JE; Hwang, SJ; Jo, HH; Kim, EJ; Kim, JH; Kim, MR; Kim, SY; Kwon, DJ; Lew, YO; Lim, YT | 1 |
1 other study(ies) available for sb 203580 and equol
Article | Year |
---|---|
Antioxidant effects of equol on bovine aortic endothelial cells.
Topics: Animals; Antioxidants; Aorta; Apoptosis; Cattle; Cytoprotection; Endothelium, Vascular; Equol; Hydrogen Peroxide; Imidazoles; Isoflavones; p38 Mitogen-Activated Protein Kinases; Phytoestrogens; Proto-Oncogene Proteins c-bcl-2; Pyridines; Reactive Oxygen Species; Tetrazolium Salts; Thiazoles | 2008 |